Pulmonary embolism: a practical approach to update risk stratification and treatment decisions based on the guidelines

References

• Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3–14. doi: 10.1007/s11239-015-1311-6
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340–1347. doi: 10.1161/CIRCRESAHA.115.306841
   PubMed Web of Science ®Google Scholar
• Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost. 2010;8:1716–1722. doi: 10.1111/J.1538-7836.2010.03938.X
   PubMed Web of Science ®Google Scholar
• Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation. 2005;112(2):112. doi: 10.1161/CIRCULATIONAHA.105.551374
   Web of Science ®Google Scholar
• Lehnert P, Lange T, Møller CH, et al. Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost. 2018;118(3):539–546. doi: 10.1160/TH17-08-0531/ID/JR170531-3/BIB
   PubMed Web of Science ®Google Scholar
• Monreal M. Fatal pulmonary embolism or bleeding in patients with venous thromboembolism: implications of real-life data. Thromb Res. 2019;181(Suppl 1):S6–S9. doi: 10.1016/S0049-3848(19)30358-5
   PubMedGoogle Scholar
• Konstantinides SV, Meyer G, Galié N, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54(3). doi: 10.1183/13993003.01647-2019
   PubMed Web of Science ®Google Scholar
• Miller GAH, Sutton GC, Kerr IH, et al. Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br Med J. 1971;2:681–684. doi: 10.1136/BMJ.2.5763.681
   PubMedGoogle Scholar
• Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–1830. doi: 10.1161/CIR.0B013E318214914F
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352. doi: 10.1016/J.CHEST.2015.11.026
   PubMed Web of Science ®Google Scholar
• Casazza F, Becattini C, Bongarzoni A, et al. Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). Thromb Res. 2012;130(6):847–852. doi: 10.1016/J.THROMRES.2012.08.292
   PubMed Web of Science ®Google Scholar
• Lin BW, Schreiber DH, Liu G, et al. Therapy and outcomes in massive pulmonary embolism from the emergency medicine pulmonary embolism in the real world registry. Am J Emerg Med. 2012;30(9):1774–1781. doi: 10.1016/J.AJEM.2012.02.012
   PubMed Web of Science ®Google Scholar
• Kucher N, Rossi E, De Rosa M, et al. Massive pulmonary embolism. Circulation. 2006;113(4):577–582. doi: 10.1161/CIRCULATIONAHA.105.592592
   PubMed Web of Science ®Google Scholar
• Quezada CA, Bikdeli B, Barrios D, et al. Meta-analysis of prevalence and short-term prognosis of hemodynamically unstable patients with symptomatic acute pulmonary embolism. Am J Cardiol. 2019;123(4):684–689. doi: 10.1016/J.AMJCARD.2018.11.009
   PubMed Web of Science ®Google Scholar
• Stein PD, Matta F, Hughes PG, et al. Nineteen-year trends in mortality of patients hospitalized in the United States with high-risk pulmonary embolism. Am J Med. 2021;134(10):1260–1264. doi: 10.1016/J.AMJMED.2021.01.026
   PubMed Web of Science ®Google Scholar
• Kuo WT, Gould MK, Louie JD, et al. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol. 2009;20(11):1431–1440. doi: 10.1016/J.JVIR.2009.08.002
   PubMed Web of Science ®Google Scholar
• Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041. doi: 10.1164/RCCM.200506-862OC
   PubMed Web of Science ®Google Scholar
• Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–1389. doi: 10.1001/ARCHINTERNMED.2010.199
   PubMedGoogle Scholar
• Elias A, Mallett S, Daoud-Elias M, et al. Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e010324. doi: 10.1136/BMJOPEN-2015-010324
   PubMed Web of Science ®Google Scholar
• Becattini C, Agnelli G, Lankeit M, et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J. 2016;48(3):780–786. doi: 10.1183/13993003.00024-2016
   PubMed Web of Science ®Google Scholar
• Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–1411. doi: 10.1056/NEJMOA1302097
   PubMed Web of Science ®Google Scholar
• Sanchez O, Charles-Nelson A, Ageno W, et al. Reduced-dose intravenous thrombolysis for acute intermediate–high-risk pulmonary embolism: rationale and design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost. 2022;122(5):857–866. doi: 10.1055/A-1653-4699
   PubMedGoogle Scholar
• Bova C, Sanchez O, Prandoni P, et al. Identification of intermediate-risk patients with acute symptomatic Pulmonary embolism. Eur Respir J. 2014;44(3):694–703. doi: 10.1183/09031936.00006114
   PubMed Web of Science ®Google Scholar
• Bova C, Vanni S, Prandoni P, et al. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism. Thromb Res. 2018;165:107–111. doi: 10.1016/j.thromres.2018.04.002
   PubMed Web of Science ®Google Scholar
• Lankeit M, Friesen D, Schäfer K, et al. A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin Res Cardiol. 2013;102(1):73–80. doi: 10.1007/S00392-012-0498-1
   PubMed Web of Science ®Google Scholar
• Hobohm L, Hellenkamp K, Hasenfuß G, et al. Comparison of risk assessment strategies for not-high-risk pulmonary embolism. Eur Respir J. 2016;47(4):1170–1178. doi: 10.1183/13993003.01605-2015
   PubMed Web of Science ®Google Scholar
• Barco S, Vicaut E, Klok FA, et al. Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials. Eur Respir J. 2018;51(1):51. doi: 10.1183/13993003.01775-2017
   Web of Science ®Google Scholar
• Mirambeaux R, Rodríguez C, Muriel A, et al. Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism. Thromb Res. 2023;223:61–68. doi: 10.1016/J.THROMRES.2023.01.019
   PubMed Web of Science ®Google Scholar
• Bova C, Vigna E, Gentile M, et al. Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate–high-risk patients: a systematic review and meta-analysis. Intern Emerg Med. 2022;17(5):1543–1546. doi: 10.1007/S11739-022-02963-5
   PubMed Web of Science ®Google Scholar
• Solverson K, Humphreys C, Liang Z, et al. Rapid prediction of adverse outcomes for acute normotensive pulmonary embolism: derivation of the Calgary Acute Pulmonary Embolism score. ERJ Open Res. 2021;7(2):00879–2020. doi: 10.1183/23120541.00879-2020
   PubMedGoogle Scholar
• Freitas P, Santos AR, Ferreira AM, et al. Derivation and external validation of the SHIeLD score for predicting outcome in normotensive pulmonary embolism. Int J Cardiol. 2019;281:119–124. doi: 10.1016/J.IJCARD.2018.12.062
   PubMed Web of Science ®Google Scholar
• Surov A, Akritidou M, Bach AG, et al. A new index for the prediction of 30-day mortality in patients with pulmonary embolism: the pulmonary embolism mortality score (PEMS). Angiology. 2021;202(8):787. doi: 10.1177/0003319721993346
   Google Scholar
• Weekes AJ, Raper JD, Lupez K, et al. Development and validation of a prognostic tool: pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE). PLoS One. 2021;16(16):e0260036. doi: 10.1371/JOURNAL.PONE.0260036
   PubMedGoogle Scholar
• Zondag W, Mos ICM, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia study. J Thromb Haemost. 2011;9(8):1500–1507. doi: 10.1183/09031936.00093712
   PubMed Web of Science ®Google Scholar
• Zondag W, den Exter PL, Crobach MJT, et al. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost. 2013;109(1):47–52. doi: 10.1160/TH12-07-0466
   PubMed Web of Science ®Google Scholar
• Roy PM, Penaloza A, Hugli O, et al. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. Eur Heart J. 2021;42(33):3146–3157. doi: 10.1093/EURHEARTJ/EHAB373
   PubMed Web of Science ®Google Scholar
• Saif K, Kevane B, Áinle FN, et al. The role of the PERT team in 2021. Thromb Updat. 2022;6:100092. doi: 10.1016/J.TRU.2021.100092
   Google Scholar
• Rosovsky R, Zhao K, Sista A, et al. Pulmonary embolism response teams: purpose, evidence for efficacy, and future research directions. Res Pract Thromb Haemost. 2019;3(3):315–330. doi: 10.1002/RTH2.12216
   PubMed Web of Science ®Google Scholar
• Sosa DF, Lehr AL, Zhao H, et al. Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis. Eur Respir Rev. 2022;31(165):31. doi: 10.1183/16000617.0023-2022
   Web of Science ®Google Scholar
• Artac I, Omar T, Karakayali M, et al. Assessment of the relationship between C-reactive protein to albumin ratio and late-term mortality in patients with acute pulmonary embolism. Asian Cardiovasc Thorac Ann. 2023;31(4):332–339. doi: 10.1177/02184923231167310
   PubMedGoogle Scholar
• Jiménez D, Tapson V, Yusen RD, et al. Revised paradigm for acute pulmonary embolism prognostication and treatment. Am J Respir Crit Care Med. 2023;208(5):524–527. doi: 10.1164/RCCM.202212-2234VP/SUPPL_FILE/DISCLOSURES.PDF
   PubMed Web of Science ®Google Scholar